Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis

被引：1
|
作者：
Magnuson, W. J. [1 ]
Amini, A. [2 ]
Patil, T. [3 ]
Kavanagh, B. D. [2 ]
Camidge, D. R. [4 ]
Braunstein, S. E. [5 ]
Boreta, L. [5 ]
Attia, A. [6 ]
Rana, N. [6 ]
Contessa, J. N. [1 ]
Gettinger, S. N. [7 ]
Lester-Coll, N. H. [1 ]
Yu, J. B. [8 ]
Chiang, V. L. [9 ]
机构：
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[2] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO USA
[3] Univ Colorado, Dept Internal Med, Denver, CO 80202 USA
[4] Univ Colorado, Dept Med Oncol, Denver, CO 80202 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA
[7] Yale Univ, Dept Med Oncol, New Haven, CT USA
[8] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
[9] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [31] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Minehiko Inomata
    Masahiro Matsumoto
    Isami Mizushima
    Kana Hayashi
    Zenta Seto
    Kotaro Tokui
    Chihiro Taka
    Seisuke Okazawa
    Kenta Kambara
    Shingo Imanishi
    Toshiro Miwa
    Ryuji Hayashi
    Shoko Matsui
    Kazuyuki Tobe
    The Egyptian Journal of Bronchology, 2022, 16
  • [32] The Impact of Clinical and Molecular Profile of Resected EGFR-Mutant Non-Small Cell Lung Cancer on the Risk of Developing Brain Metastases
    Moskovitz, M.
    Cabanero, M.
    Torchia, J.
    Sorotsky, H.
    Weiss, J.
    Pintilie, M.
    Leighl, N.
    Bradbury, P.
    Liu, G.
    Zadeh, G.
    Doherty, M.
    Kia, A.
    Torti, D.
    Tsao, M.
    Pugh, T.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1005 - S1006
  • [33] Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
    Naito, Yoichi
    Goto, Koichi
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1027 - 1040
  • [34] ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer
    Desai, Aakash
    Vazquez, Tadana A.
    Arce, Keishla M.
    Corassa, Marcelo
    Mack, Philip C.
    Gray, Jhanelle E.
    Pellini, Bruna
    CANCERS, 2024, 16 (05)
  • [35] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [36] Patritumab Deruxtecan Is Efficacious in EGFR-Mutant Non-Small Cell Lung Cancer
    Zhang, H.
    Yu, X.
    Ye, J.
    Li, H.
    Hu, J.
    Tan, Y.
    CANCER DISCOVERY, 2023, 13 (12) : 2501 - 2501
  • [37] Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors on Brain Metastases in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Zhou, Qing
    Zhang, Xuchao
    Xu, Chongrui
    Yang, Jinji
    Yang, Xuening
    An, Shejuan
    Chen, Zhihong
    Su, Jian
    Wang, Binchao
    Huang, Yisheng
    Wang, Zhen
    Huang, Yujuan
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S398 - S398
  • [38] Osimertinib in EGFR-mutant non-small cell lung carcinoma
    Lorenz, Judith
    PNEUMOLOGIE, 2023, 77 (11): : 847 - 847
  • [39] Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
    Chen, Lanyi Nora
    Ma, Xin
    Herzberg, Benjamin
    Henick, Brian S.
    Biswas, Anup K.
    Acharyya, Swarnali
    Shu, Catherine A.
    ONCOLOGIST, 2024,
  • [40] Upfront cranial radiotherapy for EGFR mutant non-small cell lung cancer with brain metastases
    Kim, M. Y.
    Kang, M. K.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S743 - S743
12345